.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
McKesson
Daiichi Sankyo
Boehringer Ingelheim
Baxter
Cerilliant
Accenture
Colorcon
Mallinckrodt

Generated: December 15, 2017

DrugPatentWatch Database Preview

Patents Expiring in 2018

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-001Oct 11, 2017RXYesNo► Subscribe► Subscribe► Subscribe
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-002Dec 30, 2004RXYesNo► Subscribe► Subscribe► SubscribeYY
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-008Dec 30, 2004RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY OR SPINAL CORD INJURY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-006Dec 30, 2004RXYesNo► Subscribe► Subscribe► SubscribeYY
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-004Dec 30, 2004RXYesNo► Subscribe► Subscribe► SubscribeYY
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-001Dec 30, 2004RXYesNo► Subscribe► Subscribe► SubscribeYMANAGEMENT OF FIBROMYALGIA
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-008Dec 30, 2004RXYesYes► Subscribe► Subscribe► SubscribeYY
Pfizer IncLYRICA CRpregabalinTABLET, EXTENDED RELEASE;ORAL209501-002Oct 11, 2017RXYesNo► Subscribe► Subscribe► SubscribeYY
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-002Dec 30, 2004RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY OR SPINAL CORD INJURY, POSTHERPETIC NEURALGIA, AND FIBROMYALGIA
Pf Prism CvLYRICApregabalinCAPSULE;ORAL021446-008Dec 30, 2004RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF PAIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Argus Health
Chinese Patent Office
Chubb
Fish and Richardson
Citi
Colorcon
Fuji
Covington
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot